Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies

被引:3
作者
Farrugia, Albert [1 ]
Kreil, Thomas R. [2 ]
机构
[1] Univ Western Australia, Dept Surg, Crawley, WA, Australia
[2] Baxter BioSci, Global Pathogen Safety, Vienna, Austria
关键词
WEST-NILE-VIRUS; TRANSFUSION SAFETY; ESTIMATED RISK; TRANSMISSION; INFECTION; AMERICA; US;
D O I
10.1111/trf.12933
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:224 / 226
页数:3
相关论文
共 23 条
[1]  
AABB, 2014, AABB ASS B, V14-03
[2]  
[Anonymous], 2013, AM SOC PLANT BIOL
[3]   Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat? [J].
Appassakij, Hatsadee ;
Khuntikij, Paiwon ;
Kemapunmanus, Marisa ;
Wutthanarungsan, Rochana ;
Silpapojakul, Khachornsakdi .
TRANSFUSION, 2013, 53 (10) :2567-2574
[4]   Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002 [J].
Biggerstaff, BJ ;
Petersen, LR .
TRANSFUSION, 2003, 43 (08) :1007-1017
[5]   Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007 [J].
Brouard, Cecile ;
Bernillon, Pascale ;
Quatresous, Isabelle ;
Pillonel, Josiane ;
Assal, Azzedine ;
De Valk, Henriette ;
Desenclos, Jean-Claude .
TRANSFUSION, 2008, 48 (07) :1333-1341
[6]  
European Medicines Agency, 1999, CPMPBWP39097 EUR MED
[7]  
European Medicines Agency, 1996, CPMPBWP26895 EUR MED
[8]   The mantra of blood safety: time for a new tune? [J].
Farrugia, A .
VOX SANGUINIS, 2004, 86 (01) :1-7
[9]  
Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
[10]  
Food and Drug Administration, 2009, GUID IND US NUCL AC